The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Evaluating the Effects of Psycho-oncological Education on Distress and Quality of Life in Solid Tumor Cancer Patients
- Conditions
- Quality of Life
- Interventions
- Other: Education
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2015-11-20
- Target Recruit Count
- 28
- Registration Number
- NCT02370836
Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
- Conditions
- Cervical Intraepithelial Neoplasia Grade 2/3High-risk HPV (Any Strain)
- Interventions
- First Posted Date
- 2015-02-03
- Last Posted Date
- 2021-04-28
- Target Recruit Count
- 30
- Registration Number
- NCT02354534
- Locations
- 🇺🇸
Johns Hopkins Outpatient Center, Baltimore, Maryland, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Greater Baltimore Medical Center, Towson, Maryland, United States
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
- Conditions
- Hematologic MalignanciesGraft-Versus-Host Disease
- Interventions
- Biological: Activated PTCy-MILs
- First Posted Date
- 2015-01-21
- Last Posted Date
- 2025-01-07
- Target Recruit Count
- 32
- Registration Number
- NCT02342613
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer
- Conditions
- Metastatic Pancreatic Adenocarcinoma
- Interventions
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2023-07-21
- Target Recruit Count
- 47
- Registration Number
- NCT02324543
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance
- Conditions
- Castration Resistant Metastatic Prostate Cancer
- Interventions
- First Posted Date
- 2014-11-10
- Last Posted Date
- 2020-11-06
- Target Recruit Count
- 222
- Registration Number
- NCT02286921
- Locations
- 🇺🇸
Piedmont Cancer Institute, Atlanta, Georgia, United States
🇺🇸University of Kansas Cancer Center, Kansas City, Kansas, United States
🇺🇸SKCCC at Johns Hopkins, Baltimore, Maryland, United States
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2014-10-08
- Last Posted Date
- 2024-08-27
- Target Recruit Count
- 39
- Registration Number
- NCT02259621
- Locations
- 🇨🇦
Johnathan Spicer, Montréal, Quebec, Canada
🇺🇸Johns Hopkins at Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab
- Conditions
- Previously Treated Metastatic Adenocarcinoma of the Pancreas
- Interventions
- First Posted Date
- 2014-09-17
- Last Posted Date
- 2021-04-06
- Target Recruit Count
- 93
- Registration Number
- NCT02243371
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound
- Conditions
- Prostate CancerAdenocarcinoma of the Prostate
- Interventions
- Radiation: Brachytherapy
- First Posted Date
- 2014-08-26
- Last Posted Date
- 2023-03-13
- Target Recruit Count
- 45
- Registration Number
- NCT02225925
- Locations
- 🇺🇸
The SKCCC at Johns Hopkins, Baltimore, Maryland, United States
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
- Conditions
- Bone Marrow Failure SyndromesSevere Aplastic Anemia
- Interventions
- Procedure: Bone marrow transplantRadiation: TBIDrug: Mycophenolic acid mofetil
- First Posted Date
- 2014-08-25
- Last Posted Date
- 2023-03-10
- Target Recruit Count
- 18
- Registration Number
- NCT02224872
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
🇺🇸Medical College of Wisconsin/Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Locations
- 🇸🇬
Johns Hopkins Singapore, Singapore, Singapore